Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
7.23Price to Free Cash Flow
VS
Market
Sector
Industry
History
$ 4.15Close
$ 1.25 - $ 4.32 52-Week Range
Ticker Information
Ticker
BDTXCompany Name
BLACK DIAMOND THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQBLACK DIAMOND THERAPEUTICS INC - Price to Free Cash Flow Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BDTX - P/FCF Historical data
| Date | Free Cash Flow | Market Capitalization | Price to Free Cash Flow |
|---|---|---|---|
| 6/30/2025 | $ 17.95M | $ 129.81M | 7.23 |
| 3/31/2025 | $ 12.41M | $ 99.51M | 8.02 |
| 12/31/2024 | $ -62.21M | $ 107.66M | 0 |
| 9/30/2024 | $ -61.12M | $ 183.9M | 0 |
| 6/30/2024 | $ -68.24M | $ 282.81M | 0 |
| 3/31/2024 | $ -67.82M | $ 379.71M | 0 |
| 12/31/2023 | $ -66.66M | $ 195.49M | 0 |
| 9/30/2023 | $ -74.63M | $ 98.62M | 0 |
| 6/30/2023 | $ -72.7M | $ 171.75M | 0 |
| 3/31/2023 | $ -76.69M | $ 66.45M | 0 |
Key Performance Insights, Last 5 Years
- BLACK DIAMOND THERAPEUTICS INC's latest trailing twelve months (TTM) P/FCF stands at 0.
- Over the past 5 years, BLACK DIAMOND THERAPEUTICS INC's average P/FCF has been 7.62.
- The median P/FCF for BLACK DIAMOND THERAPEUTICS INC during this period was 7.62
- BLACK DIAMOND THERAPEUTICS INC reached its highest P/FCF over the past 5 years at 8.02.
- The lowest P/FCF recorded by BLACK DIAMOND THERAPEUTICS INC in the same timeframe 7.23
BLACK DIAMOND THERAPEUTICS INC's P/FCF vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/FCF Benchmarks
Similar metrics to P/FCF:
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow - [Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
Definition of Price to Free Cash Flow
[Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].Market Cap / FCF
(=) P/FCF P/FCF for BLACK DIAMOND THERAPEUTICS INC is calculated as follows: Market Cap [ $ 1.22B ] / FCF [ $ -43.92M ]
(=) P/FCF [ 0 ] BDTX - Price to Free Cash Flow, Last 5 years
7.23
Minimum
Jun 30, 2025
8.02
Maximum
Mar 31, 2025
7.62
Average
7.62
Median
P/FCF Benchmark AnalysisMarket
The chart above depicts the distribution of P/FCF for companies in the Total Stock Market. The average P/FCF of the companies is 18.31 with a standard deviation of 12.92.
The following table provides additional summary stats:
P/FCF in the Market:
| filtered constituents | 2.23K |
|---|---|
| min | 0.06 |
| max | 60.45 |
| average | 18.31 |
| median | 14.73 |
| std | 12.92 |